Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study

British Journal of Cancer

Volumn 101, Issue 4, 2009, Pages 575-581

  Wethal, T ^a   Lund, M B ^a   Edvardsen, T ^a   Foss, S D ^a   Pripp, A H ^b   Holte, H ^b   Kjekshus, J ^a   Fossa A ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiac valves; Cardiomyopathy; Lymphoma

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BLEOMYCIN; CHLORAMBUCIL; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; DIAGNOSTIC IMAGING; DRUG USE; FEMALE; FOLLOW UP; HEART VENTRICLE REMODELING; HODGKIN DISEASE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MYOCARDIAL DISEASE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; AORTIC VALVE; ECHOCARDIOGRAPHY; HEART VALVE DISEASES; HEART VENTRICLES; HODGKIN DISEASE; HUMANS; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MITRAL VALVE; NEOPLASM STAGING; RADIOTHERAPY; SURVIVORS; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 68749112454     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605191     Document Type: Article

References (31)

1. Adabag AS, Dykoski R, Ward H, Anand IS (2004) Critical stenosis of aortic and mitral valves after mediastinal irradiation. Catheter Cardiovasc Interv 63: 247-250
2. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22: 3139-3148
3. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, van Leeuwen FE (2007) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109: 1878-1886
4. Apter S, Shemesh J, Raanani P, Portnoy O, Thaler M, Zissin R, Ezra D, Rozenman J, Pfeffer R, Hertz M (2006) Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. Coron Artery Dis 17: 145-151
5. Basavaraju SR, Easterly CE (2002) Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 29: 2391-2403
6. Beckman JA, Thakore A, Kalinowski BH, Harris JR, Creager MA (2001) Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll Cardiol 37: 761-765
7. Belham M, Kruger A, Mepham S, Faganello G, Pritchard C (2007) Monitoring left ventricular function in adults receiving anthracycline-containing chemotherapy. Eur J Heart Fail 9: 409-414
8. Boice Jr JD (2007) An affair of the heart. J Natl Cancer Inst 99: 186-187
9. Bonow RO, Carabello BA, Chatterjee K, de Jr LA, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith Jr SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 48: e1-e148
10. Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA, Kasper CE, Robison LL, Oeffinger KC (2005) Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 23: 6508-6515
11. Ferme C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, Van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den NE, Gyan E, Monconduit M, Divine M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vie B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M (2007) Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Eng J Med 357: 1916-1927
12. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I (2003) Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42: 743-749
13. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL (2007) Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25: 43-49
14. Hudson MM, Poquette CA, Lee J, Greenwald CA, Shah A, Luo X, Thompson EI, Wilimas JA, Kun LE, Crist WM (1998) Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 16: 3592-3600
15. Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290: 2831-2837
16. King LJ, Hasnain SN, Webb JA, Kingston JE, Shafford EA, Lister TA, Shamash J, Reznek RH (1999) Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology 213: 167-172
17. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxor-ubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23: 2629-2636
18. Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K (1996) Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 75: 591-595
19. Matsumoto Y, Adams V, Walther C, Kleinecke C, Brugger P, Linke A, Walther T, Mohr FW, Schuler G (2009) Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair. Eur Heart J 30: 346-355
20. Meinardi MT, Gietema JA, van Veldhuisen DJ, van der Graaf WT, de Vries EG, Sleijfer DT (2000) Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 26: 429-447
21. National Cancer Institute (2008) http://seer.cancer.gov/faststats/sites. php?stat=Incidence&site=Hodgkin+Lymphoma&x=18&y=14, (Accessed on October 8, 2008)
22. Patel DA, Kochanski J, Suen AW, Fajardo LF, Hancock SL, Knox SJ (2006) Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. Cancer 106: 718-725
23. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352: 20-28
24. Silber JH, Cnaan A, Clark BJ, Paridon SM, Chin AJ, Rychik J, Hogarty AN, Cohen MI, Barber G, Rutkowski M, Kimball TR, Delaat C, Steinherz LJ, Zhao H (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22: 820-828
25. Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339: 900-905
26. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83: 897-902
27. Sugihara T, Hattori Y, Yamamoto Y, Qi F, Ichikawa R, Sato A, Liu MY, Abe K, Kanno M (1999) Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation 100: 635-641
28. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford JA, Rohatiner AZ, Linch DC (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 99: 206-214
29. Wallace KB (2003) Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 93: 105-115
30. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE (2005) Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 131: 561-578
31. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16: 777-802